Home
Selecta Biosciences

Selecta Biosciences Market Share Analysis for November 2025

Health > Biotechnology and Pharmaceuticals

Domainselectabio.com

Year Founded2007

Employees51 - 200

Annual Revenue$25M - $50M

Selecta Biosciences

Selecta Biosciences (including company regionals)

selectabio.com

See more website traffic and engagement information

Selecta Biosciences Revenue up to November 2025 is 25M - 50M

revenue generated by Selecta Biosciences top domains

Selecta Biosciences top domains revenue over 3 years

Revenue for Selecta Biosciences top domains

selectabio.com25M - 50M

See more with Sales Intelligence

Total visits to Selecta Biosciences's top domains

Understand Selecta Biosciences market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Selecta Biosciences's top domains

Analyze Selecta Biosciences engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Selecta Biosciences's top domains

See how Selecta Biosciences keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Selecta Biosciences top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Selecta Biosciences

These are the website technologies, by industry, used by Selecta Biosciences top domains

Widget (4)

Twemoji

Advertising (3)

PubMatic

Conversion & Analytics (2)

Google Analytics

Mobile (2)

Meta Viewport

More Technologies

7

See all

News & Signals from Selecta Biosciences

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsSelecta Biosciences, Inc. acquires Cartesian Therapeutics, Inc..Selecta Biosciences Inc. (Nasdaq: SELB) said Monday morning it had acquired Gaithersburg, Maryland-based Cartesian Therapeutics Inc., a developer of treatments for autoimmune diseases.

NewsSelecta Biosciences, Inc. receives financing of $60.3M in private financing.In connection with the merger, Selecta announced a $60.25 million private financing led by Timothy A. Springer, Ph.D., member of the Selecta Board of Directors.

NewsSelecta Biosciences, Inc. partnered with Cartesian Therapeutics, Inc. on Nov 13th '23.Selecta Biosciences announces merger with Cartesian Therapeutics.